Sort
30,917 grants matching “tumor microenvironment”
Preventing follicular lymphoma progression and transformation through precision therapy
$407,355Wendy Beguelin · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA
The Role of FOXCI in Basal-like Breast Cancer
$407,313Xiaojiang Cui · Cedars-Sinai Medical Center · R01 · FY2022 · CA
The role of fibroblasts in the activities of tissue penetrating peptides
$407,309Kazuki Sugahara · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2012 · CA
Dissecting the Sox2-orchestrated transcriptional network that governs immune resistance in tumor initiating cells
$407,298Yuxuan Phoenix Miao · University Of Chicago · R01 · FY2024 · CA
Dissecting the Sox2-orchestrated transcriptional network that governs immune resistance in tumor initiating cells
$407,298Yuxuan Phoenix Miao · University Of Chicago · R01 · FY2025 · CA
Multi-color Mapping of Cancer Molecular Signatures and Tumor microenvironment
$407,268Jenny J Yang · Georgia State University · R33 · FY2019 · CA
METALLOPROTEINASES AND MAMMARY GLAND REMODELING
$407,234University Of California San Francisco · R01 · FY2001 · CA
Rewired Metabolism Regulates Vessel Normalization and Immunosuppression
$407,228Xiang Zhang · Baylor College Of Medicine · R01 · FY2022 · CA
Rewired Metabolism Regulates Vessel Normalization and Immunosuppression
$407,228Xiang Zhang · Baylor College Of Medicine · R01 · FY2023 · CA
The Role of HMGB1 in autophagy deficiency-induced liver pathology
$407,228Xiao-Ming Yin · Tulane University Of Louisiana · R01 · FY2020 · DK
Single-cell and imaging data integration software to spatially resolve the tumor microenvironment
$407,184Elana Fertig · Johns Hopkins University · U01 · FY2021 · CA
Integrative Somatic and Germline Computational Biology to Redefine Clinical Actionability in Solid Tumors
$407,175Eliezer M Van Allen · Dana-Farber Cancer Inst · R01 · FY2018 · CA
Integrative Somatic and Germline Computational Biology to Redefine Clinical Actionability in Solid Tumors
$407,175Eliezer M Van Allen · Dana-Farber Cancer Inst · R01 · FY2022 · CA
Optimizing Therapeutic STING Agonism in Triple Negative Breast Cancer
$407,175Thanh Uyen Barbie · Dana-Farber Cancer Inst · R01 · FY2021 · CA
Integrative Somatic and Germline Computational Biology to Redefine Clinical Actionability in Solid Tumors
$407,175Eliezer M Van Allen · Dana-Farber Cancer Inst · R01 · FY2020 · CA
Integrative Somatic and Germline Computational Biology to Redefine Clinical Actionability in Solid Tumors
$407,175Eliezer M Van Allen · Dana-Farber Cancer Inst · R01 · FY2021 · CA
Optimizing Therapeutic STING Agonism in Triple Negative Breast Cancer
$407,175Thanh Uyen Barbie · Dana-Farber Cancer Inst · R01 · FY2022 · CA
Optimizing Therapeutic STING Agonism in Triple Negative Breast Cancer
$407,175Thanh Uyen Barbie · Dana-Farber Cancer Inst · R01 · FY2025 · CA
Metabolism Informs Intertumoral & Intratumoral Heterogeneity
$407,147Jeremy N Rich · Cleveland Clinic Lerner Com-Cwru · R01 · FY2015 · NS
Bio-orthogonal Mid-Infrared Photothermal Imaging of Cancer Metabolism
$407,113Ji-Xin Cheng · Boston University (Charles River Campus) · R33 · FY2024 · CA
Bio-orthogonal Mid-Infrared Photothermal Imaging of Cancer Metabolism
$407,113Ji-Xin Cheng · Boston University (Charles River Campus) · R33 · FY2025 · CA
Targeting NQO1+ tumor to trigger innate and adaptive immunity
$407,082Xiumei Huang · Indiana University Indianapolis · R01 · FY2021 · CA
Project 3 Cerchietti
$407,063Leandro C Cerchietti · Weill Medical Coll Of Cornell Univ · P01 · FY2025 · CA
Non-viral gene therapy for cancer pain
$407,053Brian L Schmidt · New York University · R01 · FY2016 · DE
Nanovectors for Characterization and Destruction of Breast Tumor Vasculature
$407,049Mauro Ferrari · Methodist Hospital Research Institute · R01 · FY2010 · CA